SB1 Markets on Thursday upgraded Swedish medical technology company Getinge (GETI-B.ST) to buy from neutral and raised the price target to 220.00 kronor from 202.00 kronor.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
RBC Capital Markets reiterated Enbridge's (ENB.TO, ENB) outperform rating and C$79 price target in a Tuesday note after the bank recently hosted investor meetings with Enbridge Chief Financial Officer Pat Murray.key themes from the meeting include the evolving Western Canadian Sedimentary Basin energy landscape with crude oil production levels positioned to rise and support capital-efficient pipeline expansions like MLO1/MLO2. Other key themes include the company's ability to deliver or outperform its 5% near-term growth objective, and any potential change to Enbridge's capital allocation philosophy "amid a long runway of growth opportunities ahead".According to RBC, investors were interested in understanding Enbridge's outlooks for WCSB crude oil production and egress, notably following the recent Canada-Alberta Implementation Agreement. Updates on the Flanagan South Pipeline and Southern Access Extension Pipeline binding open seasons were also a focus, although RBC said there appears to be few concerns on whether MLO2 will proceed and be successful in capturing further market share. Separately, as we await news on the proposed west coast crude oil pipeline by the Alberta government, RBC noted Enbridge re-emphasized the importance of sequencing production, permitting, and pipelines (in that order) to successfully deliver infrastructure that meets long-term customer needs. "Accordingly, having permit durability and producer support ought to be crucial pre-requisites for any industry proponent of this project," the bank added.Investors were also interested in Enbridge's next multi-year growth rate update, with thisrate currently at 5% over the medium-term outlook (2026+) for EBITDA, DCF/share and EPS. The discussions suggest that the ingredients are present for Enbridge to maintain, if not upgrade, the 5% growth rate through the end of the decade, RBC said.RBC noted there continues to be investor interest in Enbridge's capital allocation framework, particularly as the company faces a significant organic growth runway and as the energy macro landscape suggests potential opportunities to accelerate the company's pace of investment going forward (including via M&A).Enbridge at last look was down near 0.7% on the Toronto Stock Exchange.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $77.56, Change: $-0.37, Percent Change: -0.47%
Ormat Technologies (ORA) has an average rating of overweight and mean price target of $133.75, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Kepler Cheuvreux on Wednesday upgraded British engineering company Weir Group (WEIR.L) to buy from hold and reduced its price target to 30 pounds sterling from 32 pounds.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)